Boning Niu

486 total citations
19 papers, 366 citations indexed

About

Boning Niu is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Boning Niu has authored 19 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Boning Niu's work include RNA Interference and Gene Delivery (5 papers), Immune cells in cancer (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Boning Niu is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Immune cells in cancer (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Boning Niu collaborates with scholars based in China, United States and Hong Kong. Boning Niu's co-authors include Xiao-kun Zhang, Jingjing Xie, Li Kong, Conglian Yang, Zhiping Zhang, Yuehuang Wu, Yuanyuan Guo, Hu Zhou, Zhiping Zhang and Xianya Qin and has published in prestigious journals such as Nature Communications, ACS Nano and Chemical Engineering Journal.

In The Last Decade

Boning Niu

19 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boning Niu China 11 154 139 124 78 52 19 366
Suhuan Dai China 9 163 1.1× 218 1.6× 162 1.3× 39 0.5× 45 0.9× 9 395
Yihong He China 12 177 1.1× 104 0.7× 120 1.0× 37 0.5× 76 1.5× 20 420
Guanru Wang China 10 183 1.2× 257 1.8× 178 1.4× 63 0.8× 66 1.3× 21 481
Prajakta Kulkarni India 10 143 0.9× 201 1.4× 195 1.6× 25 0.3× 57 1.1× 20 423
Xinchun Xu China 11 419 2.7× 131 0.9× 203 1.6× 71 0.9× 56 1.1× 18 663
Disha Marwaha India 11 201 1.3× 141 1.0× 138 1.1× 48 0.6× 63 1.2× 18 427
Yuesong Wu China 8 121 0.8× 117 0.8× 103 0.8× 74 0.9× 33 0.6× 20 320
Hadi Sadeghzadeh Iran 10 195 1.3× 126 0.9× 148 1.2× 51 0.7× 73 1.4× 15 464

Countries citing papers authored by Boning Niu

Since Specialization
Citations

This map shows the geographic impact of Boning Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boning Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boning Niu more than expected).

Fields of papers citing papers by Boning Niu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boning Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boning Niu. The network helps show where Boning Niu may publish in the future.

Co-authorship network of co-authors of Boning Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Boning Niu. A scholar is included among the top collaborators of Boning Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boning Niu. Boning Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Zhang, Fangming, Kexin Cui, Boning Niu, et al.. (2025). An immunogenic cell death dual-nanoamplifier for the reverse of chemotherapy resistance and immune escape in metastatic colon cancer. Nano Today. 62. 102678–102678. 3 indexed citations
2.
Wang, Shilong, Wei Chen, Li Kong, et al.. (2024). ROS-responsive biomimetic nanovesicles to plaque microenvironment in targeted therapy of atherosclerosis. Nano Today. 59. 102530–102530. 8 indexed citations
3.
Qiao, Qi, Xiaonan Li, Yi Wang, et al.. (2024). Hybrid biomineralized nanovesicles to enhance inflamed lung biodistribution and reduce side effect of glucocorticoid for ARDS therapy. Journal of Controlled Release. 369. 746–764. 10 indexed citations
4.
Wang, Yi, Boning Niu, Yang Li, et al.. (2024). Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis. Advanced Healthcare Materials. 13(28). e2401723–e2401723. 9 indexed citations
5.
Niu, Boning, et al.. (2024). CCL9/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-β. Acta Pharmaceutica Sinica B. 14(8). 3711–3729. 10 indexed citations
6.
Hu, Qian, et al.. (2024). Colon Targeting pH‐Responsive Coacervate Microdroplets for Treatment of Ulcerative Colitis. Small. 20(33). e2311890–e2311890. 19 indexed citations
7.
Li, Xiaonan, Qi Qiao, Qian Hu, et al.. (2024). Engineered Biomimetic Nanovesicles Based on Neutrophils for Hierarchical Targeting Therapy of Acute Respiratory Distress Syndrome. ACS Nano. 18(2). 1658–1677. 23 indexed citations
8.
Yu, Yulin, Yang Li, Xianya Qin, et al.. (2024). Self-generated double-stranded RNA for enhancing tumor immunotherapy and metastasis inhibition. Nano Today. 55. 102173–102173. 5 indexed citations
9.
Qiao, Qi, Xiaonan Li, Kexin Cui, et al.. (2023). Apoptotic neutrophil-mediated inflammatory microenvironment regulation for the treatment of ARDS. Nano Today. 52. 101946–101946. 9 indexed citations
10.
Niu, Boning, Xiaohong Chen, Sheng Lu, et al.. (2023). Discovery of 5-(Pyrimidin-2-ylamino)-1H-indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 66(23). 15847–15866. 9 indexed citations
11.
12.
Wang, Lu, Xinyi Chen, Lu Zhang, et al.. (2022). CAR cell design strategies in solid tumors. International Immunopharmacology. 113(Pt A). 109345–109345. 6 indexed citations
13.
Qiao, Qi, Xiong Liu, Kexin Cui, et al.. (2022). Hybrid Biomimetic Nanovesicles to Drive High Lung Biodistribution and Prevent Cytokine Storm for ARDS Treatment. ACS Nano. 16(9). 15124–15140. 28 indexed citations
14.
Niu, Boning, Jie Liu, Ben Lv, et al.. (2021). Interplay between transforming growth factor-β and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis. Nature Communications. 12(1). 2809–2809. 28 indexed citations
15.
Qin, Xianya, Conglian Yang, Dan Zhang, et al.. (2021). Cell‐Derived Biogenetic Gold Nanoparticles for Sensitizing Radiotherapy and Boosting Immune Response against Cancer. Small. 17(50). e2103984–e2103984. 61 indexed citations
17.
Niu, Boning, Yuehuang Wu, Mingyu Li, et al.. (2019). Enhanced cancer therapy of celastrol in vitro and in vivo by smart dendrimers delivery with specificity and biosafety. Chemical Engineering Journal. 383. 123228–123228. 51 indexed citations
18.
Niu, Boning, et al.. (2018). Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells. Journal of Colloid and Interface Science. 527. 141–150. 19 indexed citations
19.
Guo, Yuanyuan, Boning Niu, Qingle Song, et al.. (2016). RGD-decorated redox-responsived-α-tocopherol polyethylene glycol succinate–poly(lactide) nanoparticles for targeted drug delivery. Journal of Materials Chemistry B. 4(13). 2338–2350. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026